Closing Perspectives on MM Treatment and Care
Brea C. Lipe, MD closes this series highlighting the vast landscape of effective treatments and those on the horizon.
Integrating New Approaches to MM Treatment
Brea C. Lipe, MD reflects on how the PERSEUS trial results may affect future treatment approaches.
PERSEUS Trial Adverse Events and Safety Profiles
Brea C. Lipe, MD explains common grade 3 and grade 4 adverse events observed in the PERSEUS trial.
PERSEUS Trial Outcome Analysis
Brea C. Lipe, MD highlights key takeaways and patient outcomes from the PERSEUS phase three trial.
PERSEUS Trial Design and Overview
Brea C. Lipe, MD explains the trial design and patient population of PERSEUS phase three trial.
A Unique Drug Delivery Technology for MM
Brea C. Lipe, MD describes the unique treatment technology explored in the PERSEUS phase three trial.
Unmet Needs and Standards of Care in Multiple Myeloma
Brea C. Lipe, MD, discusses the evolving landscape of multiple myeloma treatment, highlighting the current abundance of drugs and the challenges associated with optimizing their use.
Lipe Discusses Therapeutic Options for a Patient With Transplant-Ineligible Multiple Myeloma
"I think it’s important to know that this can change over time, what is defined as transplant eligibility, so getting the transplant center involved early can be helpful."